UTRN and Duchenne muscular dystrophy: On the other hand, utrophin upregulation ameliorates muscle pathology in mdx mice and leads to increased AChR clustering and improved morphology of NMJs [155], which shows that either utrophin- or dystrophin-based therapies could be beneficial for the treatment of DMD [64].